世界の転移性前立腺がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Metastatic Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5858 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、109ページ • 納品方法：Eメール（納期：3日） • 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、転移性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（単体、複合、単体/複合）、用途別市場規模（病院、ドラッグストア、オンライン薬局）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・転移性前立腺がん治療の市場動向 ・企業の競争状況、市場シェア ・転移性前立腺がん治療の種類別市場規模と予測2016-2027（単体、複合、単体/複合） ・転移性前立腺がん治療の用途別市場規模と予測2016-2027（病院、ドラッグストア、オンライン薬局） ・転移性前立腺がん治療の北米市場規模2016-2027（アメリカ、カナダ） ・転移性前立腺がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・転移性前立腺がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・転移性前立腺がん治療の中南米市場規模2016-2027（メキシコ、ブラジル） ・転移性前立腺がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（AB Science、BeiGene、eFFECTOR Therapeutics、Immunomedics(Gilead Sciences, Inc.)、Myovant Biosciences、SeleXel、Zenith Epigenetics Ltd.、VasGene Therapeutics, Inc.、Telix Pharmaceuticals、Arvinas Inc.、Amgen、Genentech） ・結論

Metastatic prostate cancer is a type of prostate cancer which spreads to the other parts of body such as bones or lymph nodes.

Market Analysis and Insights: Global Metastatic Prostate Cancer Treatment Market
The global Metastatic Prostate Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Metastatic Prostate Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Metastatic Prostate Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Metastatic Prostate Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Metastatic Prostate Cancer Treatment market.

Global Metastatic Prostate Cancer Treatment Scope and Market Size
Metastatic Prostate Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Metastatic Prostate Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Mono
Combination
Mono/Combination

Segment by Application
Hospital
Drug Store
Online Pharmacy

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AB Science
BeiGene
eFFECTOR Therapeutics
Immunomedics(Gilead Sciences, Inc.)
Myovant Biosciences
SeleXel
Zenith Epigenetics Ltd.
VasGene Therapeutics, Inc.
Telix Pharmaceuticals
Arvinas Inc.
Amgen
Genentech

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Mono
1.2.3 Combination
1.2.4 Mono/Combination
1.3 Market by Application
1.3.1 Global Metastatic Prostate Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Drug Store
1.3.4 Online Pharmacy
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Metastatic Prostate Cancer Treatment Market Perspective (2016-2027)
2.2 Metastatic Prostate Cancer Treatment Growth Trends by Regions
2.2.1 Metastatic Prostate Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Metastatic Prostate Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Metastatic Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Metastatic Prostate Cancer Treatment Industry Dynamic
2.3.1 Metastatic Prostate Cancer Treatment Market Trends
2.3.2 Metastatic Prostate Cancer Treatment Market Drivers
2.3.3 Metastatic Prostate Cancer Treatment Market Challenges
2.3.4 Metastatic Prostate Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue
3.1.1 Global Top Metastatic Prostate Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Metastatic Prostate Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Metastatic Prostate Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Metastatic Prostate Cancer Treatment Revenue
3.4 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio
3.4.1 Global Metastatic Prostate Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Metastatic Prostate Cancer Treatment Revenue in 2020
3.5 Metastatic Prostate Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
3.7 Date of Enter into Metastatic Prostate Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Metastatic Prostate Cancer Treatment Breakdown Data by Type
4.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Metastatic Prostate Cancer Treatment Breakdown Data by Application
5.1 Global Metastatic Prostate Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Metastatic Prostate Cancer Treatment Market Size (2016-2027)
6.2 North America Metastatic Prostate Cancer Treatment Market Size by Type
6.2.1 North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Metastatic Prostate Cancer Treatment Market Size by Application
6.3.1 North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Metastatic Prostate Cancer Treatment Market Size by Country
6.4.1 North America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Metastatic Prostate Cancer Treatment Market Size (2016-2027)
7.2 Europe Metastatic Prostate Cancer Treatment Market Size by Type
7.2.1 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Metastatic Prostate Cancer Treatment Market Size by Application
7.3.1 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Metastatic Prostate Cancer Treatment Market Size by Country
7.4.1 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Metastatic Prostate Cancer Treatment Market Size (2016-2027)
9.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Type
9.2.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Application
9.3.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Metastatic Prostate Cancer Treatment Market Size by Country
9.4.1 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AB Science
11.1.1 AB Science Company Details
11.1.2 AB Science Business Overview
11.1.3 AB Science Metastatic Prostate Cancer Treatment Introduction
11.1.4 AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.1.5 AB Science Recent Development
11.2 BeiGene
11.2.1 BeiGene Company Details
11.2.2 BeiGene Business Overview
11.2.3 BeiGene Metastatic Prostate Cancer Treatment Introduction
11.2.4 BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.2.5 BeiGene Recent Development
11.3 eFFECTOR Therapeutics
11.3.1 eFFECTOR Therapeutics Company Details
11.3.2 eFFECTOR Therapeutics Business Overview
11.3.3 eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Introduction
11.3.4 eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.3.5 eFFECTOR Therapeutics Recent Development
11.4 Immunomedics(Gilead Sciences, Inc.)
11.4.1 Immunomedics(Gilead Sciences, Inc.) Company Details
11.4.2 Immunomedics(Gilead Sciences, Inc.) Business Overview
11.4.3 Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Introduction
11.4.4 Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.4.5 Immunomedics(Gilead Sciences, Inc.) Recent Development
11.5 Myovant Biosciences
11.5.1 Myovant Biosciences Company Details
11.5.2 Myovant Biosciences Business Overview
11.5.3 Myovant Biosciences Metastatic Prostate Cancer Treatment Introduction
11.5.4 Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.5.5 Myovant Biosciences Recent Development
11.6 SeleXel
11.6.1 SeleXel Company Details
11.6.2 SeleXel Business Overview
11.6.3 SeleXel Metastatic Prostate Cancer Treatment Introduction
11.6.4 SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.6.5 SeleXel Recent Development
11.7 Zenith Epigenetics Ltd.
11.7.1 Zenith Epigenetics Ltd. Company Details
11.7.2 Zenith Epigenetics Ltd. Business Overview
11.7.3 Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Introduction
11.7.4 Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.7.5 Zenith Epigenetics Ltd. Recent Development
11.8 VasGene Therapeutics, Inc.
11.8.1 VasGene Therapeutics, Inc. Company Details
11.8.2 VasGene Therapeutics, Inc. Business Overview
11.8.3 VasGene Therapeutics, Inc. Metastatic Prostate Cancer Treatment Introduction
11.8.4 VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.8.5 VasGene Therapeutics, Inc. Recent Development
11.9 Telix Pharmaceuticals
11.9.1 Telix Pharmaceuticals Company Details
11.9.2 Telix Pharmaceuticals Business Overview
11.9.3 Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Introduction
11.9.4 Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.9.5 Telix Pharmaceuticals Recent Development
11.10 Arvinas Inc.
11.10.1 Arvinas Inc. Company Details
11.10.2 Arvinas Inc. Business Overview
11.10.3 Arvinas Inc. Metastatic Prostate Cancer Treatment Introduction
11.10.4 Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.10.5 Arvinas Inc. Recent Development
11.11 Amgen
11.11.1 Amgen Company Details
11.11.2 Amgen Business Overview
11.11.3 Amgen Metastatic Prostate Cancer Treatment Introduction
11.11.4 Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.11.5 Amgen Recent Development
11.12 Genentech
11.12.1 Genentech Company Details
11.12.2 Genentech Business Overview
11.12.3 Genentech Metastatic Prostate Cancer Treatment Introduction
11.12.4 Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021)
11.12.5 Genentech Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Metastatic Prostate Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Mono
Table 3. Key Players of Combination
Table 4. Key Players of Mono/Combination
Table 5. Global Metastatic Prostate Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Metastatic Prostate Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Metastatic Prostate Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Metastatic Prostate Cancer Treatment Market Share by Regions (2016-2021)
Table 9. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Metastatic Prostate Cancer Treatment Market Share by Regions (2022-2027)
Table 11. Metastatic Prostate Cancer Treatment Market Trends
Table 12. Metastatic Prostate Cancer Treatment Market Drivers
Table 13. Metastatic Prostate Cancer Treatment Market Challenges
Table 14. Metastatic Prostate Cancer Treatment Market Restraints
Table 15. Global Metastatic Prostate Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Metastatic Prostate Cancer Treatment Market Share by Players (2016-2021)
Table 17. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2020)
Table 18. Ranking of Global Top Metastatic Prostate Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Metastatic Prostate Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Metastatic Prostate Cancer Treatment Product Solution and Service
Table 22. Date of Enter into Metastatic Prostate Cancer Treatment Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 26. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Metastatic Prostate Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 30. Global Metastatic Prostate Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 62. AB Science Company Details
Table 63. AB Science Business Overview
Table 64. AB Science Metastatic Prostate Cancer Treatment Product
Table 65. AB Science Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 66. AB Science Recent Development
Table 67. BeiGene Company Details
Table 68. BeiGene Business Overview
Table 69. BeiGene Metastatic Prostate Cancer Treatment Product
Table 70. BeiGene Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 71. BeiGene Recent Development
Table 72. eFFECTOR Therapeutics Company Details
Table 73. eFFECTOR Therapeutics Business Overview
Table 74. eFFECTOR Therapeutics Metastatic Prostate Cancer Treatment Product
Table 75. eFFECTOR Therapeutics Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 76. eFFECTOR Therapeutics Recent Development
Table 77. Immunomedics(Gilead Sciences, Inc.) Company Details
Table 78. Immunomedics(Gilead Sciences, Inc.) Business Overview
Table 79. Immunomedics(Gilead Sciences, Inc.) Metastatic Prostate Cancer Treatment Product
Table 80. Immunomedics(Gilead Sciences, Inc.) Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 81. Immunomedics(Gilead Sciences, Inc.) Recent Development
Table 82. Myovant Biosciences Company Details
Table 83. Myovant Biosciences Business Overview
Table 84. Myovant Biosciences Metastatic Prostate Cancer Treatment Product
Table 85. Myovant Biosciences Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 86. Myovant Biosciences Recent Development
Table 87. SeleXel Company Details
Table 88. SeleXel Business Overview
Table 89. SeleXel Metastatic Prostate Cancer Treatment Product
Table 90. SeleXel Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 91. SeleXel Recent Development
Table 92. Zenith Epigenetics Ltd. Company Details
Table 93. Zenith Epigenetics Ltd. Business Overview
Table 94. Zenith Epigenetics Ltd. Metastatic Prostate Cancer Treatment Product
Table 95. Zenith Epigenetics Ltd. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 96. Zenith Epigenetics Ltd. Recent Development
Table 97. VasGene Therapeutics, Inc. Company Details
Table 98. VasGene Therapeutics, Inc. Business Overview
Table 99. VasGene Therapeutics, Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 100. VasGene Therapeutics, Inc. Recent Development
Table 101. Telix Pharmaceuticals Company Details
Table 102. Telix Pharmaceuticals Business Overview
Table 103. Telix Pharmaceuticals Metastatic Prostate Cancer Treatment Product
Table 104. Telix Pharmaceuticals Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 105. Telix Pharmaceuticals Recent Development
Table 106. Arvinas Inc. Company Details
Table 107. Arvinas Inc. Business Overview
Table 108. Arvinas Inc. Metastatic Prostate Cancer Treatment Product
Table 109. Arvinas Inc. Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 110. Arvinas Inc. Recent Development
Table 111. Amgen Company Details
Table 112. Amgen Business Overview
Table 113. Amgen Metastatic Prostate Cancer Treatment Product
Table 114. Amgen Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 115. Amgen Recent Development
Table 116. Genentech Company Details
Table 117. Genentech Business Overview
Table 118. Genentech Metastatic Prostate Cancer Treatment Product
Table 119. Genentech Revenue in Metastatic Prostate Cancer Treatment Business (2016-2021) & (US$ Million)
Table 120. Genentech Recent Development
Table 121. Research Programs/Design for This Report
Table 122. Key Data Information from Secondary Sources
Table 123. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Metastatic Prostate Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Mono Features
Figure 3. Combination Features
Figure 4. Mono/Combination Features
Figure 5. Global Metastatic Prostate Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 6. Hospital Case Studies
Figure 7. Drug Store Case Studies
Figure 8. Online Pharmacy Case Studies
Figure 9. Metastatic Prostate Cancer Treatment Report Years Considered
Figure 10. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 11. Global Metastatic Prostate Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 12. Global Metastatic Prostate Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 13. Global Metastatic Prostate Cancer Treatment Market Share by Regions (2022-2027)
Figure 14. Global Metastatic Prostate Cancer Treatment Market Share by Players in 2020
Figure 15. Global Top Metastatic Prostate Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metastatic Prostate Cancer Treatment as of 2020
Figure 16. The Top 10 and 5 Players Market Share by Metastatic Prostate Cancer Treatment Revenue in 2020
Figure 17. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 18. Global Metastatic Prostate Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 19. North America Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 20. North America Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 21. North America Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 22. North America Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 23. United States Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Canada Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 27. Europe Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 28. Europe Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 29. Germany Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. France Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. U.K. Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Italy Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Russia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Nordic Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 37. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 38. Asia-Pacific Metastatic Prostate Cancer Treatment Market Share by Region (2016-2027)
Figure 39. China Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. Japan Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. South Korea Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. Southeast Asia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. India Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Australia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 47. Latin America Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 48. Latin America Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 49. Mexico Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Brazil Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Type (2016-2027)
Figure 53. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Application (2016-2027)
Figure 54. Middle East & Africa Metastatic Prostate Cancer Treatment Market Share by Country (2016-2027)
Figure 55. Turkey Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. Saudi Arabia Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. UAE Metastatic Prostate Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. AB Science Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 59. BeiGene Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 60. eFFECTOR Therapeutics Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 61. Immunomedics(Gilead Sciences, Inc.) Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 62. Myovant Biosciences Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 63. SeleXel Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 64. Zenith Epigenetics Ltd. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 65. VasGene Therapeutics, Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 66. Telix Pharmaceuticals Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 67. Arvinas Inc. Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 68. Amgen Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 69. Genentech Revenue Growth Rate in Metastatic Prostate Cancer Treatment Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---